172 related articles for article (PubMed ID: 8032897)
1. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
Goettl VM; Larson AA
Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
[TBL] [Abstract][Full Text] [Related]
2. MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity.
Sun X; Larson AA
Neuroreport; 1993 Sep; 4(10):1147-50. PubMed ID: 7693010
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
4. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
[TBL] [Abstract][Full Text] [Related]
5. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
[TBL] [Abstract][Full Text] [Related]
6. The quinoxalinediones antagonise the visual firing of sustained retinal ganglion cells.
Kay CD; Ikeda H
Eur J Pharmacol; 1989 May; 164(2):381-4. PubMed ID: 2569410
[TBL] [Abstract][Full Text] [Related]
7. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
8. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
Sun X; Larson AA
Neuroscience; 1993 Jun; 54(3):773-9. PubMed ID: 8101361
[TBL] [Abstract][Full Text] [Related]
9. Differences in NMDA receptor antagonist-induced locomotor activity and [3H]MK-801 binding sites in short-sleep and long-sleep mice.
Velardo MJ; Simpson VJ; Zahniser NR
Alcohol Clin Exp Res; 1998 Oct; 22(7):1509-15. PubMed ID: 9802536
[TBL] [Abstract][Full Text] [Related]
10. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster.
Colwell CS; Menaker M
J Biol Rhythms; 1992; 7(2):125-36. PubMed ID: 1611128
[TBL] [Abstract][Full Text] [Related]
11. Postnatal lead exposure and MK-801 sensitivity.
Cory-Slechta DA
Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003
[TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
Parada-Turska J; Turski WA
Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
[TBL] [Abstract][Full Text] [Related]
13. The NMDA receptor complex modulates clonidine-induced increases in growth hormone levels in rats.
Mazzola-Pomietto P; Aulakh CS; Murphy DL
Pharmacol Biochem Behav; 1995 Feb; 50(2):305-7. PubMed ID: 7740072
[TBL] [Abstract][Full Text] [Related]
14. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization.
Ujike H; Tsuchida H; Kanzaki A; Akiyama K; Otsuki S
Life Sci; 1992; 50(22):1673-81. PubMed ID: 1534132
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice.
Turski L; Bressler K; Klockgether T; Stephens DN
Neurosci Lett; 1990 May; 113(1):66-71. PubMed ID: 1973274
[TBL] [Abstract][Full Text] [Related]
16. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat.
Kristensen JD; Karlsten R; Gordh T; Berge OG
Pain; 1994 Jan; 56(1):59-67. PubMed ID: 8159442
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor antagonists block the effects of light on circadian behavior in the mouse.
Colwell CS; Foster RG; Menaker M
Brain Res; 1991 Jul; 554(1-2):105-10. PubMed ID: 1834303
[TBL] [Abstract][Full Text] [Related]
18. The roles of different types of glutamate receptors involved in the mediation of nucleus submedius (Sm) glutamate-evoked antinociception in the rat.
Xie YF; Tang JS; Jia H
Brain Res; 2003 Oct; 988(1-2):146-53. PubMed ID: 14519536
[TBL] [Abstract][Full Text] [Related]
19. The competitive NMDA antagonist CPP blocks MK-801-elicited popping behavior in mice.
Deutsch SI; Rosse RB; Riggs RL; Koetzner L; Mastropaolo J
Neuropsychopharmacology; 1996 Oct; 15(4):329-31. PubMed ID: 8887986
[TBL] [Abstract][Full Text] [Related]
20. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
